Angiodynamics Inc. Stock
Price
Target price
€13.40
€13.40
-0.740%
-0.1
-0.740%
-
18.08.26 / Stuttgart Stock Exchange
WKN: A0B9A5 / Name: AngioDynamics / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Angiodynamics Inc. Stock
The price for the Angiodynamics Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.740%).
Pros and Cons of Angiodynamics Inc. in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Angiodynamics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Angiodynamics Inc. | -0.740% | -1.471% | 13.559% | 79.866% | 25.234% | 71.795% | -42.241% |
| Orthofix Medical Inc. | -2.890% | -2.326% | -17.647% | -29.412% | -34.884% | -49.091% | -74.850% |
| Lantheus Holdings Inc | -0.460% | -0.687% | -7.864% | 80.663% | 51.573% | 43.069% | - |
| Natera Inc | -0.150% | -0.627% | 13.527% | 93.813% | 36.751% | 433.465% | 211.445% |
News
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
Key Points
- Interested in AngioDynamics, Inc.? Here are five stocks we like better.
- MedTech is expected to become AngioDynamics’ majority revenue source in fiscal 2027, rising from 47% of
AngioDynamics Q4 Earnings Call Highlights
Key Points
- Interested in AngioDynamics, Inc.? Here are five stocks we like better.
- Revenue growth was led by med tech: AngioDynamics reported Q4 revenue up 8% to $86.6 million and full-year